Ask AI

Expert Perspectives on Updates and Advances in Individualizing CLL/SLL Therapy Across the Disease Course

Dive deeper into the guidelines with these practical, expert-driven insights on individualizing therapy for patients with CLL/SLL, including selecting optimal first-line treatment and sequencing of treatment following relapse, through a certified on-demand webcast and downloadable slides from a live event as well as a ClinicalThought commentary with key takeaways.

Share

Program Content

No activities added yet

Provided by

ProCE Banner

Provided by the National Comprehensive Cancer Network (NCCN) in collaboration with Clinical Care Options, LLC.

Supporters

Supported by educational grants from AbbVie Inc., Bristol-Myers Squibb, and Lilly.

AbbVie Inc.

Bristol Myers Squibb

Lilly

Partners

Clinical Care Options, LLC

ProCE Banner